Silent variants in CFTR and F9 may decrease protein abundance through alterations to translation elongation, leading to cystic fibrosis and Hemophilia B, respectively (Kirchner et al, 2017; Simhadri et al, 2017). This evidence concerns the gene F9 and cystic fibrosis.